- Home
- VYGR vs BRY Comparison
VYGR vs BRY Comparison
Compare VYGR & BRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYGR
- BRY
- Stock Information
- Founded
- VYGR 2013
- BRY 1909
- Country
- VYGR United States
- BRY United States
- Employees
- VYGR N/A
- BRY N/A
- Industry
- VYGR Biotechnology: Pharmaceutical Preparations
- BRY Oil & Gas Production
- Sector
- VYGR Health Care
- BRY Energy
- Exchange
- VYGR Nasdaq
- BRY Nasdaq
- Market Cap
- VYGR 191.9M
- BRY 186.1M
- IPO Year
- VYGR 2015
- BRY N/A
- Fundamental
- Price
- VYGR $3.17
- BRY $2.92
- Analyst Decision
- VYGR Strong Buy
- BRY Hold
- Analyst Count
- VYGR 9
- BRY 1
- Target Price
- VYGR $14.86
- BRY $5.00
- AVG Volume (30 Days)
- VYGR 282.0K
- BRY 920.9K
- Earning Date
- VYGR 05-06-2025
- BRY 05-08-2025
- Dividend Yield
- VYGR N/A
- BRY 11.97%
- EPS Growth
- VYGR N/A
- BRY N/A
- EPS
- VYGR N/A
- BRY N/A
- Revenue
- VYGR $66,958,000.00
- BRY $830,412,000.00
- Revenue This Year
- VYGR N/A
- BRY N/A
- Revenue Next Year
- VYGR $2.04
- BRY $2.60
- P/E Ratio
- VYGR N/A
- BRY N/A
- Revenue Growth
- VYGR N/A
- BRY N/A
- 52 Week Low
- VYGR $2.75
- BRY $2.11
- 52 Week High
- VYGR $9.55
- BRY $7.81
- Technical
- Relative Strength Index (RSI)
- VYGR 40.49
- BRY 58.65
- Support Level
- VYGR $3.46
- BRY $2.36
- Resistance Level
- VYGR $3.69
- BRY $2.63
- Average True Range (ATR)
- VYGR 0.18
- BRY 0.14
- MACD
- VYGR 0.00
- BRY 0.08
- Stochastic Oscillator
- VYGR 0.00
- BRY 91.80
About VYGR Voyager Therapeutics Inc.
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
About BRY Berry Corporation (bry)
Berry Corp (bry) is a western United States independent upstream energy company with a focus on the conventional, long-lived oil reserves in the San Joaquin basin of California. Its operating segments includes Exploration and Production (E&P) and Well Servicing and Abandonment. The company generates maximum revenue from the Exploration and Production (E&P) segment.